622
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Predictors of All-Cause Mortality in Patients with Stable COPD: Medical Co-morbid Conditions or High Depressive Symptoms

, , &

References

  • Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Co-morbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008; 5(4):549–555.
  • Patel AR, Hurst JR. Extrapulmonary co-morbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5(5):647–662.
  • Schnell K, Weiss CO, Lee T, Krishnan JA, Leff B, Wolff JL, The prevalence of clinically-relevant co-morbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999–2008. BMC Pulm Med 2012; 12(26):567–574.
  • Anecchino C, Rossi E, Fanizza C, De Rosa M, Tognoni G, Romero M, Prevalence of chronic obstructive pulmonary disease and pattern of co-morbidities in a general population. Int J Chron Obstruct Pulmon Dis 2007; 2(4):567–574.
  • Almagro P, Cabrera FJ, Diez J, Boixeda R, Ortiz B, Murio C, Co-morbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD. The ESMI study. Chest 2012; 142(5):1126–1133.
  • Groenewegen KH, Schols AM, Wouters EF. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003; 124(2):459–467.
  • Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, Mortality after hospitalization for COPD. Chest 2002; 121(5):1441–1448.
  • Holguin F, Folch E, Redd SC, Mannino DM. Co-morbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001. Chest 2005; 128(4):2005–2011.
  • Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003; 163(10):1180–1186.
  • Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10(12):2794–2800.
  • Marti S, Munoz X, Rios J, Morell F, Ferrer J. Body weight and co-morbidity predict mortality in COPD patients treated with oxygen therapy. Eur Respir J 2006; 27(4):689–696.
  • Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171(6):591–597.
  • Soler-Cataluna JJ, Sanchez-Sanchez L, Martinez-Garcia MA, Sanchez PR, Salcedo E, Navarro M. Mid-arm muscle area is a better predictor of mortality than body mass index in COPD. Chest 2005; 128(4):2108–2115.
  • de Voogd JN, Wempe JB, Koeter GH, Postema K, van Sonderen E, Ranchor AV, Depressive symptoms as predictors of mortality in patients with COPD. Chest 2009; 135(3):619–625.
  • Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47(12):1019–1024.
  • Varray A, Prefaut C. Exercise capacity in patients with respiratory disease: procedure and results. Eur Resp Rev 1995; 5:51–58.
  • Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40(5):373–383.
  • Van Hemert B, Ormel J. Nederlandse versie van de Hospital Anxiety and Depression Scale (HADS); vragenlijst en regels voor scoring –Dutch version of the Hospital Anxiety and Depression Scale (HADS); questionnaire and scoring instructions. Leiden/Groningen: Vakgroep psychiatrie/Vakgroep gezondheidswetenschappen; 1993.
  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6):361–370.
  • Derogatis LR. SCL-90: administration, scoring and procedures manual-I for the R(evised) version. Baltimore: Johns Hopkins University School of Medicine, Clinical Research Unit; 1977.
  • Arrindell WA, Ettema JHM. SCL-90: Handleiding voor een multidimensionele psychopathologie-indicator-SCL-90: Manual for a multifaceted measure of psychopathology. Lisse: Swets & Zeitlinger; 2003.
  • Wagena EJ, Arrindell WA, Wouters EF, van Schayck CP. Are patients with COPD psychologically distressed? Eur Respir J 2005; 26(2):242–248.
  • Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: Role of co-morbidities. Eur Respir J 2006; 28(6):1245–1257.
  • Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Co-morbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186(2):155–161.
  • de Voogd JN, Wempe JB, Postema K, van Sonderen E, Ranchor AV, Coyne JC, More evidence that depressive symptoms predict mortality in COPD patients: is type D personality an alternative explanation? Ann Behav Med 2009; 38(2):86–93.
  • Moberg M, Vestbo J, Martinez G, Williams JE, Ladelund S, Lange P, Validation of the i-BODE Index as a predictor of hospitalization and mortality in patients with COPD participating in pulmonary rehabilitation. COPD 2013 epub ahead of print.
  • National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume–reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003 05/22; 2014/01;348(21):2059–2073.
  • Marin JM, Soriano JB, Carrizo SJ, Boldova A, Celli BR. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010; 182(3):325–331.
  • Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of co-morbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128(4):2099–2107.
  • Noteboom B, Jenkins S, Maiorana A, Cecins N, Ng C, Hill K. Co-morbidities and medication burden in patients with chronic obstructive pulmonary disease attending pulmonary rehabilitation. J Cardiopulm Rehabil Prev 2014; 34(1):75–79.
  • Sin DD, Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107(11):1514–1519.
  • Sidney S, Sorel M, Quesenberry CP Jr, DeLuise C, Lanes S, Eisner MD. COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser Permanente Medical Care Program. Chest 2005; 128(4):2068–2075.
  • Rutten FH, Moons KG, Cramer MM, Grobbee DE, Zuithoff N, Hoes AW. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005; 331(7529):1379.
  • Macchia A, Rodriguez Moncalvo JJ, Kleinert M, Comignani PD, Gimeno G, Arakaki D, Unrecognised ventricular dysfunction in COPD. Eur Respir J 2012; 39(1):51–58.
  • Slenter RH, Sprooten RT, Kotz D, Wesseling G, Wouters EF, Rohde GG. Predictors of 1-year mortality at hospital admission for acute exacerbations of Chronic Obstructive Pulmonary Disease. Respiration 2012 Oct 2; 85(1):15–26.
  • Hoiseth AD, Omland T, Hagve TA, Brekke PH, Soyseth V. NT-proBNP independently predicts long term mortality after acute exacerbation of COPD—a prospective cohort study. Respir Res 2012 Oct 29;13:97–99.
  • Medina AM, Marteles MS, Saiz EB, Martinez SS, Laiglesia FR, Rodriguez JA, Prognostic utility of NT-proBNP in acute exacerbations of chronic pulmonary diseases. Eur J Intern Med 2011; 22(2):167–171.
  • Ringbaek T, Martinez G, Brondum E, Thogersen J, Morgan M, Lange P. Shuttle walking test as predictor of survival in chronic obstructive pulmonary disease patients enrolled in a rehabilitation program. J Cardiopulm Rehabil Prev 2010; 30(6):409–414.
  • Williams JE, Green RH, Warrington V, Steiner MC, Morgan MD, Singh SJ. Development of the i-BODE: validation of the incremental shuttle walking test within the BODE index. Respir Med 2012; 106(3):390–396.
  • Arnardottir RH, Emtner M, Hedenstrom H, Larsson K, Boman G. Peak exercise capacity estimated from incremental shuttle walking test in patients with COPD: a methodological study. Respir Res 2006; 7:127.
  • Luxton N, Alison JA, Wu J, Mackey MG. Relationship between field walking tests and incremental cycle ergometry in COPD. Respirology 2008; 13(6):856–862.
  • Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140(2):331–342.
  • Vestbo J, Prescott E, Almdal T, Dahl M, Nordestgaard BG, Andersen T, Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006; 173(1):79–83.
  • Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 2005; 82(1):53–59.
  • Nezu K, Kawaguchi T, Kimura M, Yasukawa M, Kushibe K, Taniguchi S, Lung volume reduction surgery and nutritional status in patients with severe emphysema. Jpn J Thorac Cardiovasc Surg 2001; 49(9):552–556.
  • Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34(5):491–496.
  • Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007; 167(1):60–67.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.